Generation of nitrotyrosine precedes activation of metalloproteinase in myocardium of hyperhomocysteinemic rats

Antioxidants and Redox Signaling

Volumn 4, Issue 5, 2002, Pages 799-804

  Sood, Harpreet S ^a   Cox, Michael J ^a   Tyagi, Suresh C ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; BETA ACTIN; GELATINASE A; HOMOCYSTEINE; METALLOPROTEINASE; NITRIC OXIDE; TISSUE INHIBITOR OF METALLOPROTEINASE 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; CARDIAC MUSCLE; CONTROLLED STUDY; ENZYME ACTIVITY; HEART INJURY; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE HYPERTROPHY; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HYPERHOMOCYSTEINEMIA; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; RIGHT COMMON CAROTID ARTERY; WESTERN BLOTTING; ZYMOGRAPHY; HEART LEFT VENTRICLE DP-DT; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; MALE; MUSCLE STRENGTH; MYOCARDIAL DISEASE; OXIDATIVE STRESS; PROTEIN URINE LEVEL; SPECTROFLUOROMETRY;

ANIMALS; BLOOD PRESSURE; ENZYME ACTIVATION; HEART; HEART RATE; HEMODYNAMIC PROCESSES; HYPERHOMOCYSTEINEMIA; KINETICS; MALE; MATRIX METALLOPROTEINASE 2; MYOCARDIUM; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; TISSUE INHIBITOR OF METALLOPROTEINASES; TYROSINE; VENTRICULAR FUNCTION, LEFT;

ANIMALIA;

EID: 0036774355     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/152308602760598954     Document Type: Article

References (29)

1. Aimes RT and Quigley JP. MMP-2 is an interstitial collagenase. J Biol Chem 270: 5872-5876, 1995.
2. Beckman JS, Beckman TW, Chen J, Marshall PA, and Freeman BA. Apparent hydroxy radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc NatlAcad Sci USA 87: 1620-1624, 1990.
3. Bescond A, Augier T, Chareyre C, Garcon D, Hornebeck W, and Charpiot P. Influence of homocysteine on matrix metalloproteinase-2 activation and activity. Biochem Biphys Res Commun 263: 498-503, 1999.
4. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
5. Buelke-Sam J, Holson JF, Bazare JJ, and Young JF. Comparative stability of physiological parameters during sustained anesthesia in rats. Lab Anim Sci 28: 157-162, 1978.
6. Ding B, Price RL, Goldsmith EC, Borg TK, Yan X, Douglas PS, Weinberg EO, Bartunek J, Thielen T, Didenko VV, and Lorell BH. Left ventricular hypertrophy in ascending aortic stenosis mice: anoikis and the progression of early failure. Circulation 101: 2854-2862, 2000.
7. Dudman NPB and Wilcken DEL. Increased plasma copper in patients with homocysteineurea due to cystathione beta synthase deficiency. Clin Chim Acta 127: 105-113, 1983.
8. Frantzen F, Faaren AL, Alfheim I, and Nordhei AK. Enzyme conversion immunoassay for determining total homocysteine in plasma or serum. Clin Chem 44: 311-316, 1998.
9. Greene J, Wang M, Liu TE, Raymond LA, Rosen C, and Shi YE. Molecular cloning and characterization of human TIMP-4. J Biol Chem 271: 30375-30380, 1996.
10. Hackam DG, Peterson JC, and Spence JD. What level of plasma homocysteine should be treated? Am J Hypertens 13: 105-110, 2000.
11. Hirohata S, Kusachi S, Murakami M, Murakami T, Samo I, Watanabe T, Komatsubara I, Kondo J, and Tsuji T. Time dependent alterations of serum MMP-1 and TIMP-1 after successful reperfusion of acute MI. Heart 78: 278-284, 1997.
12. Horton JR., Udo WE, Precht P, Balakir R, and Hasty K. Cytokine inducible MMP expression in immortalized rat chondrocytes is independent of NO stimulation. In Vitro Cell Dev Biol Anim 34: 378-384, 1998.
13. Huie RE and Padjama S. The reaction of NO with superoxide. Free Radic Res Commun 18: 195-199, 1993.
14. Miller A, Mujumdar V, Shek E, Guillot J, Angelo M, Palmer L, and Tyagi SC. Hyperhomocysteinemia induces multiorgan damage. Heart Vessels 15: 135-143, 2000.
15. Mujumdar VS and Tyagi SC. Temporal regulation of ECM components in transition from compensatory hypertrophy to decompensatory heart failure. J Hypertens 17: 261-270, 1999.
16. Mujumdar VS, Aru GM, and Tyagi SC. Induction of oxidative stress by homocyst(e)ine impairs endothelial function. J Cell Biochem 82: 491-500, 2001.
17. Radomski A, Sawicki G, Olson DM, and Radomski MW. The role of nitric oxide and metalloproteinases in the pathogenesis of hyperoxia-induced lung injury in newborn rats. Br J Pharmacol 125: 1455-1462, 1998.
18. Rajagopalan S, Meng XP, Ramasamy S, Harrison DG, and Galis ZS. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular MMP in vitro. J Clin Invest 98: 2572-2579, 1996.
19. Rolland PH, Friggi A, Barlatier A, Piquet P, Latrille V, Faye MM, Guillou J, Charpioy P, Bodard H, Ghininghelli O, Calaf R, Luccioni R, and Garcon D. Hyperhomocysteinemia-induced vascular damage in the minipigs. Circulation 91: 1161-1174, 1995.
20. Sasaki K, Hattori T, Fuj isawa T, Takahashi K, Inoue H, and Takigawa M. Nitric oxide mediates IL-1 induced gene expression of MMPs and bFGF in cultured rabbit articular chondrocytes. J Biochem (Tokyo) 123: 431-439, 1998.
21. Senior RM, Griffin GL, Eliszar CJ, Shapiro SD, Goldberg GI, and Welgus HG. Human 92-and 72-kilodalton type IV collagenases are elastases. J Biol Chem 266: 7870-7875, 1991.
22. Simon DI, Mullins ME, Jia L, Gaston B, Singel DL, and Stamler JS. Polynitrosylated proteins: Characterization, bioactivity and functional consequences. Proc Natl Acad Sci USA 93: 4736-4741, 1996.
23. Tyagi SC, Smiley LM, Mujumdar VS, Clonts B, and Parker JL. Reduction-oxidation (redox) and vascular tissue level of homocyst(e)ine in human coronary atherosclerotic lesions and role in vascular extracellular matrix remodeling and vascular tone. Mol Cell Biochem 181: 107-116, 1998.
24. Tyagi SC, Smiley LM, and Mujumdar VS. Homocysteine impairs endocardial endothelial function. Can J Physiol Pharmacol 77: 950-957, 1999.
25. Ungvari Z, Pacher P, Rischak K, Szollar L, and Koller A. Dysfunction of nitric oxide mediation in isolated rat arterioles with methionine diet-induced hyperhomocystenemia. Arterioscler Thromb Vasc Biol 19: 1899-1904, 1999.
26. Upchurch GR Jr, Welch GN, Fabian AJ, Freedman JE, Johnson JL, Keaney JF Jr, and Loscalzo J. Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase. J Biol Chem 272: 17012-17017, 1997.
27. Wollesen F, Brattstrom L, Refsum H, Ueland PM, Berglund L, and Berne C. Plasma total homocysteine and cysteine in relation to glomerular filteration rate in diabetes mellitus. Kidney Int 55: 1028-1035, 1999.
28. Yoshida Y, Nakano A, Hamasa R, Kamitsuchibashi H, Yamamoto K, Akagi H, Kitazono M, and Osame M. Patients with homocystinurea: high metal concentrations in hair, blood and urine. Acta Neurol Scand 86: 490-495, 1992.
29. Zhang X, Li H, Jin H, Ebin Z, Brodsky S, and Goligorsky MS. Effects of homocysteine on endothelial nitric oxide production. Am J Physiol 279: F671-F678, 2000.